Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia

NCT00258427 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Fanconi Anemia

Interventions

BIOLOGICAL: anti-thymocyte globulin
BIOLOGICAL: filgrastim
DRUG: busulfan
DRUG: cyclophosphamide
DRUG: fludarabine phosphate
DRUG: methylprednisolone
BIOLOGICAL: Hematopoietic stem cell transplantation

Sponsor

Masonic Cancer Center, University of Minnesota